Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alex Duval

Showing results (51-60 of 89) with videos related to

Pageof 9
Sort By:
Carcinogenesis|February 24, 2006
Detection of microsatellite instability in endometrial cancer: advantages of a panel of five mononucleotide repeats over the National Cancer Institute panel of markersYick Fu Wong, Tak Hong Cheung, Keith Wing Kit Lo, et al.
JAMA Oncology|November 20, 2018
Association of Primary Resistance to Immune Checkpoint Inhibitors in Metastatic Colorectal Cancer With Misdiagnosis of Microsatellite Instability or Mismatch Repair Deficiency StatusRomain Cohen, Elisabeth Hain, Olivier Buhard, et al.
Plos One|July 10, 2008
Nonsense-mediated mRNA decay impacts MSI-driven carcinogenesis and anti-tumor immunity in colorectal cancersJamila El-Bchiri, Agathe Guilloux, Peggy Dartigues, et al.
Annals of Surgical Oncology|September 1, 2011
Screening for Lynch syndrome in colorectal cancer: are we doing enough?Guillaume Canard, Jeremie H Lefevre, Chrystelle Colas, et al.
Bulletin Du Cancer|December 17, 2016
Immunotherapy and patients treated for cancer with microsatellite instabilityRaphaël Colle, Romain Cohen, Delphine Cochereau, et al.
Journal of the National Cancer Institute|October 7, 2010
Azathioprine-induced carcinogenesis in mice according to Msh2 genotypeAlexandra Chalastanis, Virginie Penard-Lacronique, Magali Svrcek, et al.
The Oncologist|April 6, 2023
BRAF V600E/RAS Mutations and Lynch Syndrome in Patients With MSI-H/dMMR Metastatic Colorectal Cancer Treated With Immune Checkpoint InhibitorsRaphael Colle, Sara Lonardi, Marine Cachanado, et al.
NPJ Precision Oncology|December 1, 2022
Pan-cancer landscape of AID-related mutations, composite mutations, and their potential role in the ICI responseIsaias Hernández-Verdin, Kadir C Akdemir, Daniele Ramazzotti, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 11, 2026
Beyond p53 status: the continued importance of histopathologic features for predicting lymph node metastasis in endometrial cancerAmelia Favier, Julia Le Tan, Aurélie Siret, et al.
Journal for Immunotherapy of Cancer|February 13, 2021
Adrenal gland as a sanctuary site for immunotherapy in patients with microsatellite instability-high metastatic colorectal cancerRomain Cohen, Vincent Jonchère, Christelle De La Fouchardière, et al.
Pageof 9

Showing results (51-60 of 89) with videos related to

Sort By:
Pageof 9
Carcinogenesis|February 24, 2006
Detection of microsatellite instability in endometrial cancer: advantages of a panel of five mononucleotide repeats over the National Cancer Institute panel of markersYick Fu Wong, Tak Hong Cheung, Keith Wing Kit Lo, et al.
JAMA Oncology|November 20, 2018
Association of Primary Resistance to Immune Checkpoint Inhibitors in Metastatic Colorectal Cancer With Misdiagnosis of Microsatellite Instability or Mismatch Repair Deficiency StatusRomain Cohen, Elisabeth Hain, Olivier Buhard, et al.
Plos One|July 10, 2008
Nonsense-mediated mRNA decay impacts MSI-driven carcinogenesis and anti-tumor immunity in colorectal cancersJamila El-Bchiri, Agathe Guilloux, Peggy Dartigues, et al.
Annals of Surgical Oncology|September 1, 2011
Screening for Lynch syndrome in colorectal cancer: are we doing enough?Guillaume Canard, Jeremie H Lefevre, Chrystelle Colas, et al.
Bulletin Du Cancer|December 17, 2016
Immunotherapy and patients treated for cancer with microsatellite instabilityRaphaël Colle, Romain Cohen, Delphine Cochereau, et al.
Journal of the National Cancer Institute|October 7, 2010
Azathioprine-induced carcinogenesis in mice according to Msh2 genotypeAlexandra Chalastanis, Virginie Penard-Lacronique, Magali Svrcek, et al.
The Oncologist|April 6, 2023
BRAF V600E/RAS Mutations and Lynch Syndrome in Patients With MSI-H/dMMR Metastatic Colorectal Cancer Treated With Immune Checkpoint InhibitorsRaphael Colle, Sara Lonardi, Marine Cachanado, et al.
NPJ Precision Oncology|December 1, 2022
Pan-cancer landscape of AID-related mutations, composite mutations, and their potential role in the ICI responseIsaias Hernández-Verdin, Kadir C Akdemir, Daniele Ramazzotti, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 11, 2026
Beyond p53 status: the continued importance of histopathologic features for predicting lymph node metastasis in endometrial cancerAmelia Favier, Julia Le Tan, Aurélie Siret, et al.
Journal for Immunotherapy of Cancer|February 13, 2021
Adrenal gland as a sanctuary site for immunotherapy in patients with microsatellite instability-high metastatic colorectal cancerRomain Cohen, Vincent Jonchère, Christelle De La Fouchardière, et al.
Pageof 9